These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17412296)

  • 1. Cure of chronic viral infection by neutralizing antibody treatment.
    Ejrnaes M; von Herrath MG
    Autoimmun Rev; 2007 Apr; 6(5):267-71. PubMed ID: 17412296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
    Ejrnaes M; von Herrath MG; Christen U
    Clin Dev Immunol; 2006; 13(2-4):337-47. PubMed ID: 17162375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of a chronic viral infection after interleukin-10 receptor blockade.
    Ejrnaes M; Filippi CM; Martinic MM; Ling EM; Togher LM; Crotty S; von Herrath MG
    J Exp Med; 2006 Oct; 203(11):2461-72. PubMed ID: 17030951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 plays an early role in generating virus-specific T cell anergy.
    Maris CH; Chappell CP; Jacob J
    BMC Immunol; 2007 Jun; 8():8. PubMed ID: 17570849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategies to eliminate persistent viral infections.
    Martinic MM; von Herrath MG
    Trends Immunol; 2008 Mar; 29(3):116-24. PubMed ID: 18258483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10, T cell exhaustion and viral persistence.
    Blackburn SD; Wherry EJ
    Trends Microbiol; 2007 Apr; 15(4):143-6. PubMed ID: 17336072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.
    Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H
    J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of viral infections on the population level explained by an immunoepidemiological model.
    Kostova T
    Math Biosci; 2007 Apr; 206(2):309-19. PubMed ID: 16214182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10.
    Boyle NT; Connor TJ
    Eur J Pharmacol; 2007 Oct; 572(2-3):228-38. PubMed ID: 17689526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cell dysfunction during chronic viral infection.
    Shin H; Wherry EJ
    Curr Opin Immunol; 2007 Aug; 19(4):408-15. PubMed ID: 17656078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural antibodies target virus-antibody complexes to organized lymphoid tissue.
    Matter MS; Ochsenbein AF
    Autoimmun Rev; 2008 Jun; 7(6):480-6. PubMed ID: 18558366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for persistent viral infections and associated disease.
    van der Burg SH; Arens R; Melief CJ
    Trends Immunol; 2011 Mar; 32(3):97-103. PubMed ID: 21227751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
    Wherry EJ; Ha SJ; Kaech SM; Haining WN; Sarkar S; Kalia V; Subramaniam S; Blattman JN; Barber DL; Ahmed R
    Immunity; 2007 Oct; 27(4):670-84. PubMed ID: 17950003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies.
    Ejrnaes M; von Herrath MG; Christen U
    Clin Dev Immunol; 2006 Mar; 13(1):67-77. PubMed ID: 16603445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.
    Dagenais-Lussier X; Loucif H; Murira A; Laulhé X; Stäger S; Lamarre A; van Grevenynghe J
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29301196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
    Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
    Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.